Richard Nolan Townsend, Chief Executive Officer at Lexeo Therapeutics, Inc. (LXEO), sold 7,962 shares at $17.29 ($139K) on 2024-06-10, disclosed to the SEC on 2024-06-12.
Scheduled sale ($139k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.29 | 2,962 | $51K | 36.7% |
| 2 | $17.29 | 2,962 | $51K | 36.7% |
| 3 | $18.18 | 2,038 | $37K | 26.6% |
| Total | $17.52 avg | 7,962 | $139K | 100% |
| Filing → |
| LXEO | SELL | 2026-05-20 | $17K | — | Filing → |
| LXEO | SELL | 2026-04-07 | $313K | — | Filing → |
| LXEO | SELL | 2026-02-20 | $65K | — | Filing → |